Medicamen Biotech Share Price
Small Cap | Pharmaceuticals and health care | NSE: MEDICAMEQ | BSE: 531146
₹438.85 
-3.25 (-0.74 %)
Last Updated: 29 Apr 2025 03:47 PM
BEARISH
Overview
Open (₹) 444.30
High (₹) 450.10
Low (₹) 435.65
Prev. Close (₹) 442.10
Volume 14,688
VWAP (₹) 476.59
ROCE (%) 8.32
Industry P/E 46.53
TTM P/E 75.79
P/B Ratio 2.70
Market Cap (₹) Cr.595.28
Dividend Yield (%)0.23
EPS (₹) 7.50
ROE4.61%
Sales Growth (%) 27.29
Profit Growth (%)-35.54
Day Range
450.10450.10
52 Week Range
377.00630.00
Historical Returns
Returns (6M)
-20.11 %
Returns (1Y)
-24.28 %
Returns (3Y)
-38.44 %
Returns (5Y)
-20.5 %
Returns (6M)
-20.11 %
Returns (1Y)
-24.28 %
Returns (3Y)
-38.44 %
Returns (5Y)
-20.5 %
SWOT Analysis
- Company with Low Debt
- Book value per share improving over the last 2 years
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
Technicals
Technical Rating
BEARISHRSI 54.30
MFI 67.17
ATR 32.89
Commodity Channel Index 13.60
ROC125 -16.64
ROC21 9.68
Williams %R -66.23
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 491.06 | 508.33 | 519.66 | 479.73 | 462.46 | 451.13 | 433.86 |
| Week Ago | 507.70 | 519.75 | 537.90 | 489.55 | 477.50 | 459.35 | 447.30 |
| Month Ago | 430.84 | 445.32 | 456.49 | 419.67 | 405.19 | 394.02 | 379.54 |
EMA & SMA
438.85
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 490.78
9 Day 497.18
10 Day 489.35
12 Day 482.82
14 Day 478.07
20 Day 468.96
26 Day 468.52
50 Day 479.41
100 Day 490.38
200 Day 481.43
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| GROWEL REMEDIES LIMITED | bulk | Sell | 22 Mar, 2024 | ₹421.86 | 2,00,000 | NSE |
| SHIVALIK RASAYAN LIMITED | bulk | Buy | 22 Mar, 2024 | ₹421.86 | 2,00,000 | NSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 22 Mar, 2025 | Shivalik Rasayan Limited | Acquisition | ₹494.14 | 21,000 | NSE |
| 22 Mar, 2025 | Shivalik Rasayan Limited | Acquisition | ₹494.14 | 21,000 | NSE |
| 17 Dec, 2024 | Geetika Madan | Disposal | ₹572.29 | 2,000 | NSE |
| 17 Dec, 2024 | Geetika Madan | Disposal | ₹612.17 | 313 | NSE |
| 17 Dec, 2024 | Geetika Madan | Disposal | ₹448.65 | 3,000 | NSE |
| 18 Sept, 2024 | Geetika Madan | Disposal | ₹475.86 | 1,490 | NSE |
| 18 Sept, 2024 | Geetika Madan | Disposal | ₹398.20 | 1,000 | NSE |
| 26 Mar, 2024 | Geetika Madan | Disposal | ₹428.07 | 2,449 | NSE |
| 23 Mar, 2024 | Shivalik Rasayan Limited | Acquisition | ₹424.36 | 2,00,000 | NSE |
| 23 Mar, 2024 | Growel Remedies Limited | Disposal | ₹419.43 | 2,00,000 | NSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 29 May, 2024 | Rs.1.0000 per share(10%)Final Dividend (BC & XD dates revised) | 19 Sept, 2024 | 01 Jan, 1970 |
| 11 Aug, 2023 | Rs.1.0000 per share(10%)Final Dividend | 20 Sept, 2023 | 01 Jan, 1970 |
| 25 May, 2022 | Rs.1.0000 per share(10%)Final Dividend | 19 Sept, 2022 | 01 Jan, 1970 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 25 Apr, 2025 | NSE India | Medicamen Biotech Limited has informed the Exchange regarding ''Corrigendum to the Outcome of the Meeting of Board of Directors of Medicamen Biotech Limited ( the Company ) in accordance with Regulation 30 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015''. |
| 25 Apr, 2025 | BSE India | Corrigendum to the Outcome of the meeting of the Board Meeting of Board of Directors of Medicamen Biotech Limited (\the Company\) in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations, 2015 |
| 25 Apr, 2025 | NSE India | MEDICAMEN BIOTECH LIMITED has informed the Exchange regarding Allotment of Securities |
| 25 Apr, 2025 | NSE India | Medicamen Biotech Limited has informed the Exchange regarding Board meeting held on April 24, 2025. Revised Outcome |
| 25 Apr, 2025 | BSE India | Revised outcome of Board Meeting - 24.04.2025 |
| 25 Apr, 2025 | NSE India | Medicamen Biotech Limited has informed the Exchange regarding Board meeting held on April 24, 2025. |
| 25 Apr, 2025 | BSE India | Outcome of Board Meeting - April 24, 2025 |
| 24 Apr, 2025 | NSE India | MEDICAMEN BIOTECH LIMITED has informed the Exchange regarding Allotment of Securities |
| 24 Apr, 2025 | NSE India | Medicamen Biotech Limited has informed the Exchange regarding Board meeting held on April 24, 2025 for allotment of 8,48,220 Equity Shares and 6,50,000 Fully convertible warrants |
| 24 Apr, 2025 | BSE India | We wish to inform you that the Board of Directors of the Company at their meeting held today i.e Thursday, April 24, 2025 has inter alia considered and approved the following :\r\n\r\n1. Allotment of 8,48,220 Equity Shares\r\n2.Allotment of 6,50,000 fully convertible warrants |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Preferential issue of shares | -- | 23 Feb, 2025 | 26 Feb, 2025 |
| Quarterly Results | -- | 05 Feb, 2025 | 11 Feb, 2025 |
| Quarterly Results | -- | 08 Nov, 2024 | 14 Nov, 2024 |
| Quarterly Results | -- | 08 Aug, 2024 | 13 Aug, 2024 |
| Audited Results & Final Dividend | -- | 22 May, 2024 | 29 May, 2024 |
| Quarterly Results | -- | 06 Feb, 2024 | 12 Feb, 2024 |
| Quarterly Results | -- | 03 Nov, 2023 | 10 Nov, 2023 |
| Quarterly Results | -- | 03 Aug, 2023 | 08 Aug, 2023 |
| Audited Results & Final Dividend | -- | 24 May, 2023 | 29 May, 2023 |
| Quarterly Results | -- | 01 Feb, 2023 | 10 Feb, 2023 |
Share Holding Pattern
| Owner Name | Mar, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
|---|---|---|---|---|---|
| Promoter Group | 43.16% | 42.99% | 43.21% | 43.21% | 43.6% |
| Foreign Institutions + | 0.12% | 0.06% | 0.22% | 0.17% | 0.35% |
| Domestic Institutions + | 0.69% | 0.87% | 0.67% | 0.2% | 0% |
| Government | 0.06% | 0.06% | 0% | 0% | 0% |
| Public | 55.97% | 56.02% | 55.9% | 56.42% | 56.05% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Medicamen Biotech
Medicamen Biotech is a Public Limited Listed company incorporated on 22/12/1993 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1993PLC056594 and registration number is 056594. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 172.39 Cr. and Equity Capital is Rs. 12.71 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
1993
Managing Director
-- --
NSE Symbol
MEDICAMEQ
Medicamen Biotech Management
| Name | Designation |
|---|---|
| Mr. Rahul Bishnoi | Chairman |
| Mr. Ashwani Kumar Sharma | Non Executive Director |
| Dr. Vimal Kumar Shrawat | Non Executive Director |
| Mr. Sanjay Bansal | Non Executive Director |
| Mr. Suresh Kumar Singh | Non Executive Director |
| Mr. Arun Kumar | Independent Director |
| Mr. Harish Pande | Independent Director |
| Ms. Sangeeta Bishnoi | Independent Director |
| Dr. Ravi Kumar Bansal | Independent Director |
| Mrs. Sumita Dwivedi | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,33,199.93 | ₹1,805.50  ₹1,841.60(-1.96%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,62,148.21 | ₹6,108.00  ₹6,026.50(1.35%) | ₹3,725.550 - ₹6,448.750 |
| Cipla | ₹1,24,497.77 | ₹1,541.50 ₹1,555.10(-0.87%) | ₹1,310.050 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,12,455.27 | ₹3,322.70 ₹3,335.00(-0.37%) | ₹2,513.050 - ₹3,589.950 |
| Mankind Pharma | ₹1,05,492.20 | ₹2,556.90 ₹2,560.40(-0.14%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Medicamen Biotech
What is the share price of Medicamen Biotech?
The share price of Medicamen Biotech on 29 Apr, 2025 is ₹ 438.85.
What is 52W high and 52W low share price of Medicamen Biotech?
The highest and lowest 52W share prices of Medicamen Biotech are ₹ 630.000 and ₹ 377.000
What is the market cap of Medicamen Biotech?
The market capitalization of Medicamen Biotech as of 29 Apr, 2025 is ₹ 595.28 Crores
What is the P/E ratio of Medicamen Biotech?
The current P/E ratio of Medicamen Biotech as of 29 Apr, 2025 is 46.53
What is the PB ratio of Medicamen Biotech?
The PB ratio of Medicamen Biotech as of 29 Apr, 2025 is 2.70
Top Gainers
₹322.00
₹268.38 (0.20%)
₹40.95
₹34.13 (0.20%)
₹1.57
₹1.31 (0.20%)
₹37.90
₹31.63 (0.20%)
Top Losers
₹71.01
₹79.65 (-0.11%)
₹12.16
₹13.51 (-0.10%)
₹1.51
₹1.75 (-0.14%)
₹16.74
₹18.83 (-0.11%)
Market Indices
Sensex
₹80,288.38
₹80,218.37 (0.00%)